A study shows expanding access to care through insurance has the potential to improve outcomes in adults with follicular lymphoma.
Individuals who develop frequent basal cell carcinomas may have an increased prevalence of germline mutations in DNA repair genes and an increased malignancy risk.
Dr. Dmitriy Zamarin speaks with Cancer Network about the findings of a phase II trial in platinum-resistant ovarian cancer patients.
Certain malignancies may possess a common and targetable matrix response, which affects disease pathogeneis, according to a study in Cancer Discovery.
A new study suggests that the cytokine CXCL12 could be useful as a prognostic biomarker in patients with neuroendocrine tumors of the lung.
Linda Jacobs, PhD, CRNP, director of the Cancer Survivorship Center, comments on the incidence of erectile dysfunction in childhood cancer survivors.
Survivors of oropharyngeal cancers who developed late lower cranial neuropathy reported having worse treatment-related symptoms.
New research examines the mechanisms underlying why most patients with high-grade serous ovarian cancer develop resistance to PARP inhibitors.
Optical coherence tomography and multispectral fluorescence imaging have demonstrated promising results in the early detection of ovarian cancer.
Antiretroviral therapy and rituximab show promise in aids-related diffuse large B-cell lymphoma patients.